TILT Holdings (TLLTF) Gains from Investment Securities (2021 - 2025)
TILT Holdings (TLLTF) reported Gains from Investment Securities of -$162000.0 for Q2 2025, up 81.9% on a YoY basis from -$89060.2 in Q2 2024, and down 194.19% quarter-over-quarter from $172000.0 in Q1 2025.
TILT Holdings (TLLTF) Gains from Investment Securities (2021 - 2025) Analysis & Trends
TILT Holdings has reported Gains from Investment Securities for 5 years, with the latest figure at -$162000.0 in Q2 2025.
- For the quarter ending Q2 2025, Gains from Investment Securities rose 81.9% year-over-year to -$162000.0; the trailing twelve-month figure through Jun 2025 stood at $1.1 million (up 274.07% YoY), and the FY2024 full-year result was $1.1 million, down 66.97% from the prior year.
- Gains from Investment Securities for Q2 2025 stood at -$162000.0, down from $172000.0 in the prior quarter.
- The five-year high for Gains from Investment Securities was $3.8 million in Q2 2023, with the low at -$7.2 million in Q4 2021.
- Historically, Gains from Investment Securities has averaged -$965235.3 across 5 years, with a median of -$34000.0 in 2022.
- The largest YoY upside for Gains from Investment Securities was 2720.59% in 2023 against a maximum downside of 148.2% in 2023.
- TILT Holdings' Gains from Investment Securities stood at -$7.2 million in 2021, then surged by 99.53% to -$34000.0 in 2022, then soared by 2720.59% to $891000.0 in 2023, then climbed by 7.63% to $959000.0 in 2024, then slumped by 116.89% to -$162000.0 in 2025.
- The last three Gains from Investment Securities figures came in at -$162000.0 (Q2 2025), $172000.0 (Q1 2025), and $959000.0 (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn |
| 10 | TILT Holdings | - | - | 1.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -162,000.00 |
| Jun 30, 2025 | -162,000.00 |
| Mar 31, 2025 | 172,000.00 |
| Mar 31, 2025 | 172,000.00 |
| Dec 31, 2024 | 959,000.00 |
| Dec 31, 2024 | 959,000.00 |
| Sep 30, 2024 | 105,000.00 |
| Sep 30, 2024 | 105,000.00 |
| Jun 30, 2024 | -895,000.00 |
| Jun 30, 2024 | -895,000.00 |
| Mar 31, 2024 | 901,000.00 |
| Mar 31, 2024 | 901,000.00 |
| Dec 31, 2023 | 891,000.00 |
| Dec 31, 2023 | 891,000.00 |
| Sep 30, 2023 | -1.51 Mn |
| Sep 30, 2023 | -1.51 Mn |
| Jun 30, 2023 | 3.80 Mn |
| Jun 30, 2023 | 3.80 Mn |
| Mar 31, 2023 | 67,000.00 |
| Mar 31, 2023 | 67,000.00 |